var data={"title":"Pertussis infection: Epidemiology, microbiology, and pathogenesis","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Pertussis infection: Epidemiology, microbiology, and pathogenesis</div><dl id=\"topicContributors\"><dt><span> </span>Authors:</dt><dd><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/contributors\" class=\"contributor contributor_credentials\">Paul Cornia, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/contributors\" class=\"contributor contributor_credentials\">Benjamin A Lipsky, MD, FACP, FIDSA, FRCP (London), FRCPS (Glasg)</a></dd><dt><span> </span>Section Editors:</dt><dd><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/contributors\" class=\"contributor contributor_credentials\">Stephen B Calderwood, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/contributors\" class=\"contributor contributor_credentials\">Sheldon L Kaplan, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/contributors\" class=\"contributor contributor_credentials\">Elinor L Baron, MD, DTMH</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Nov 30, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H252274975\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Pertussis, also known as &quot;whooping cough,&quot; is a highly contagious acute respiratory illness caused by <em>Bordetella pertussis</em>. A Chinese reference to &quot;the cough of 100 days&quot; by Chao Yuanfang in the early 7<sup>th</sup> century may have referred to pertussis [<a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/1\" class=\"abstract_t\">1</a>]. In 1679, Sydenham named the illness pertussis, from the Latin term meaning &quot;intense cough.&quot; These names describe the key clinical features of pertussis infection. However, the classic clinical manifestations of pertussis infection (paroxysmal cough, inspiratory whoop, and posttussive emesis) are frequently absent in adolescents and adults.</p><p>The microbiology, epidemiology, and pathogenesis of pertussis are reviewed here. The clinical manifestations, diagnosis, management, and prevention of pertussis are discussed separately. (See <a href=\"topic.htm?path=pertussis-infection-in-adolescents-and-adults-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Pertussis infection in adolescents and adults: Clinical manifestations and diagnosis&quot;</a> and <a href=\"topic.htm?path=pertussis-infection-in-infants-and-children-treatment-and-prevention\" class=\"medical medical_review\">&quot;Pertussis infection in infants and children: Treatment and prevention&quot;</a> and <a href=\"topic.htm?path=pertussis-infection-in-infants-and-children-clinical-features-and-diagnosis\" class=\"medical medical_review\">&quot;Pertussis infection in infants and children: Clinical features and diagnosis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H270844\"><span class=\"h1\">MICROBIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Pertussis is caused by the gram-negative coccobacillus <em>B. pertussis</em>, a strict human pathogen with no known animal or environmental reservoir [<a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/2\" class=\"abstract_t\">2</a>]. The organism is fastidious, surviving only a few hours in respiratory secretions and thus requiring special media for culture.</p><p>Eight additional <em>Bordetella </em>species have been described: <em>B. parapertussis</em><em><sub>hu</sub></em>, <em>B. parapertussis</em><em><sub>ov</sub></em><em> </em>(ovine-adapted parapertussis), <em>B. bronchiseptica</em>, <em>B. avium</em>, <em>B. hinzii</em>, <em>B. holmesii</em>, <em>B. trematum</em>, and <em>B. petrii </em>[<a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/3\" class=\"abstract_t\">3</a>]. Three of these species (<em>B. parapertussis</em>, <em>B. bronchiseptica</em>, and <em>B. holmesii</em>)<sub> </sub>can cause respiratory illness in humans. <em>B. parapertussis</em> may cause a spectrum of disease ranging from a nonspecific upper respiratory tract illness to classic pertussis (ie, clinically indistinguishable from that of <em>B. pertussis</em>) [<a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/4,5\" class=\"abstract_t\">4,5</a>]. <em>B. bronchiseptica</em> causes respiratory infections in a variety of mammals; human infection most often occurs in immunocompromised hosts with animal exposure [<a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/6\" class=\"abstract_t\">6</a>]. Unlike <em>B. pertussis</em>, <em>B. holmesii</em> may also cause bacteremia; asplenia is the most common risk factor, but other immunocompromising conditions have been reported [<a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/7-11\" class=\"abstract_t\">7-11</a>].</p><p class=\"headingAnchor\" id=\"H252274996\"><span class=\"h1\">EPIDEMIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Pertussis is a highly contagious respiratory illness. In adolescents and adults, infection may result in a protracted cough and is occasionally associated with substantial morbidity. In children and particularly infants, morbidity is more often substantial, and the disease may be fatal.</p><p class=\"headingAnchor\" id=\"H252275003\"><span class=\"h2\">Transmission</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The incubation period for <em>B. pertussis</em> ranges from 1 to 3 weeks but is most typically 7 to 10 days. This is in contrast with the shorter incubation period (one to three days) for viral upper respiratory infections associated with cough, such as the common cold.</p><p>Pertussis infection is spread via respiratory droplets, which are aerosolized by paroxysms of coughing [<a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/12\" class=\"abstract_t\">12</a>]. In one study, approximately one-third of exposed individuals within households developed pertussis; nearly half of asymptomatic individuals had laboratory evidence of infection, and the remainder had a mild respiratory illness (ie, nonclassical symptoms of pertussis) [<a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/13\" class=\"abstract_t\">13</a>]. Thus, asymptomatic infection is common. In addition, transmission of pertussis from an asymptomatic person to a susceptible individual may occur [<a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/14\" class=\"abstract_t\">14</a>].</p><p>Individuals with pertussis are considered infectious until they have completed five days of appropriate antibiotic treatment [<a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/15-17\" class=\"abstract_t\">15-17</a>].</p><p class=\"headingAnchor\" id=\"H252275010\"><span class=\"h2\">Incidence</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Prior to the introduction of a whole-cell vaccine in the United States in the late 1940s, pertussis was a devastating illness with a relatively high infant mortality rate. Widespread pertussis vaccination of children led to a dramatic decline in disease incidence, from a peak of more than 250,000 reported cases in 1934 to a nadir of 1010 cases in 1976 (<a href=\"image.htm?imageKey=ID%2F83297\" class=\"graphic graphic_figure graphicRef83297 \">figure 1</a>) [<a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/18\" class=\"abstract_t\">18</a>].</p><p>Cyclical epidemics occur every two to five years as they did in the prevaccine era. These epidemics have been superimposed on the steadily rising incidence in the United States and many other developed countries. The unchanged cyclical epidemic pattern of pertussis suggests that the overall circulation of <em>B. pertussis</em> in the population has not been affected by the vaccine [<a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/19\" class=\"abstract_t\">19</a>].</p><p>Since the 1970s, there has been a steady increase in reported cases in the United States [<a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/20\" class=\"abstract_t\">20</a>]; there were 27,550 reported cases and outbreaks in several states in 2010 (<a href=\"image.htm?imageKey=ID%2F73317\" class=\"graphic graphic_figure graphicRef73317 \">figure 2</a>) and more than 48,000 cases in 2012 [<a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/21,22\" class=\"abstract_t\">21,22</a>]. In 2012, the Provisional Pertussis Surveillance Report noted that the incidence of pertussis infection in adolescents and adults in the United States was 53.6 and 3.9 per 100,000, respectively [<a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/23\" class=\"abstract_t\">23</a>]. A pertussis epidemic in California was declared in June 2014 when the reported incidence was more than five times greater than baseline levels; between January 1 and November 26, a total of 9935 cases were reported, for a statewide incidence of 26 cases per 100,000 [<a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/24\" class=\"abstract_t\">24</a>]. Because pertussis is underdiagnosed in adults, the actual incidence is likely substantially higher. This was demonstrated by a study including patients &ge;18 years old who had not received pertussis vaccination in the last five years; the incidence of pertussis (based on seroepidemiologic studies) was substantially higher than the clinically reported incidence (0.84 versus 699 per 100,000 inhabitants) [<a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/25\" class=\"abstract_t\">25</a>].</p><p>The cause for the rising incidence of pertussis is not fully understood. Possible explanations include increased clinician awareness, increased public health reporting, increased availability of more sensitive diagnostic tests (particularly polymerase chain reaction [PCR]), waning vaccine-induced immunity in adolescent populations (as immunity following vaccination or infection is not lifelong) [<a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/26\" class=\"abstract_t\">26</a>], decreased use of pertussis vaccine, genetic changes in the circulating strains of pertussis, and a true increase in circulating <em>B. pertussis</em>. Widespread use of PCR testing has improved clinicians' ability to confirm the diagnosis [<a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/27,28\" class=\"abstract_t\">27,28</a>]. Numerous reports indicate waning of immunity with the acellular pertussis vaccines DTaP and Tdap.</p><p>Since 1997, acellular pertussis vaccine (DTaP) has been recommended for all five childhood doses (the last of which should be administered between ages four and six years). Prior to 1997, whole-cell pertussis vaccine (DTwP) was administered [<a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/29\" class=\"abstract_t\">29</a>]. The DTwP vaccine was effective in preventing childhood pertussis, although immunity gradually waned 5 to 10 years after completing the childhood series, resulting in risk for infection in adolescence and adulthood [<a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/30,31\" class=\"abstract_t\">30,31</a>]. Because the incidence of local reactions (pain, redness, swelling) and systemic reactions (fever, anorexia) with DTwP was relatively high [<a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/32\" class=\"abstract_t\">32</a>], childhood acellular pertussis vaccines (DTaP) were introduced in the United States in the early 1990s. Clinical trial data suggest DTaP has similar efficacy to DTwP, with a lower incidence of adverse effects [<a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/29,33\" class=\"abstract_t\">29,33</a>]; however, the currently available DTaP formulations offer less short-term protection than DTwP [<a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/34\" class=\"abstract_t\">34</a>].</p><p>Since 2005, an increased risk of pertussis has been observed in the first cohort of children who received the DTaP series as they reach 7 to 10 years of age [<a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/35\" class=\"abstract_t\">35</a>]. Similarly, several reports suggest that the immunity following administration of the fifth DTaP dose wanes more rapidly than expected [<a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/36-39\" class=\"abstract_t\">36-39</a>], leaving a gap in immunity between the last childhood dose of DTaP and the Tdap booster vaccine (which is suggested to be administered at 11 to 12 years of age) [<a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/40\" class=\"abstract_t\">40</a>]. Adolescents who received the DTaP vaccine in childhood appear to have a substantially higher risk of contracting pertussis than those who received the DTwP vaccine [<a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/41,42\" class=\"abstract_t\">41,42</a>] and the Tdap vaccine in adolescents who received DTap in childhood (rather than DTwP) [<a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/43\" class=\"abstract_t\">43</a>].</p><p>Worldwide, 90 percent of the 30 to 50 million annual cases of pertussis occur in developing countries. About 300,000 cases result in death [<a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/44\" class=\"abstract_t\">44</a>], with mortality occurring predominantly in infants (who are too young to have received vaccination) and unvaccinated or undervaccinated children.</p><p class=\"headingAnchor\" id=\"H252275017\"><span class=\"h2\">Evolving epidemiology</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In the United States, a substantial portion of the increasing incidence in reported pertussis cases since 1990 is attributable to increased rates of infection in adolescents and adults [<a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/45-48\" class=\"abstract_t\">45-48</a>]. In the prevaccine era, more than 90 percent of reported cases of pertussis occurred in children &lt;10 years old [<a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/46\" class=\"abstract_t\">46</a>]. In the late 1990s, about one-half of reported cases occurred in adolescents and adults [<a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/18\" class=\"abstract_t\">18</a>]. The incidence of reported pertussis cases among infants also increased between 1980 and 1999 [<a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/49,50\" class=\"abstract_t\">49,50</a>].</p><p><em>B. pertussis</em> infection in adolescents and adults appears to be much more common than many clinicians appreciate [<a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/27,51\" class=\"abstract_t\">27,51</a>]. This may be because the manifestations of pertussis are often less severe than in infants and children. Studies of adolescents and adults with cough illnesses lasting &ge;1 week in nonoutbreak settings indicate that pertussis is responsible for 13 to 20 percent of cases; the overwhelming majority of these patients actually had a substantially longer duration of illness (&gt;3 weeks) [<a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/27,52\" class=\"abstract_t\">27,52</a>]. The incidence of pertussis is quite low in adults with cough duration &le;4 weeks [<a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/53\" class=\"abstract_t\">53</a>]. (See <a href=\"topic.htm?path=pertussis-infection-in-adolescents-and-adults-clinical-manifestations-and-diagnosis#H248746178\" class=\"medical medical_review\">&quot;Pertussis infection in adolescents and adults: Clinical manifestations and diagnosis&quot;, section on 'Adolescents and adults'</a>.)</p><p>Adolescents and adults with unrecognized pertussis serve as a reservoir of infection for infants and children [<a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/54\" class=\"abstract_t\">54</a>]. Groups at highest risk of pertussis-related morbidity and mortality include infants (especially those younger than six months) and young children who have not been fully immunized. Epidemiologic studies have shown that most infants acquire the infection from adolescents and adults in their own household [<a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/55-59\" class=\"abstract_t\">55-59</a>]. Siblings of infants have been identified as the most common identifiable source of transmission in one study [<a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/60\" class=\"abstract_t\">60</a>], likely reflecting increased susceptibility to infection of children and adolescents who received the acellular pertussis vaccine.</p><p>Primate data suggest that the acellular pertussis vaccine may protect individuals from clinical disease, but asymptomatic or subclinical infection may still develop and result in spread to susceptible individuals [<a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/61\" class=\"abstract_t\">61</a>]. Mathematical modeling suggests that this may be an important reason for the increase in incidence in the United States and United Kingdom [<a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/14\" class=\"abstract_t\">14</a>].</p><p>An important misconception is that childhood pertussis vaccination or prior infection confers lifelong immunity. Because protective immunity wanes, booster vaccination is recommended for adolescents and adults and for pregnant women. Rates of vaccination with Tdap among adults in the United States, while improving slightly in recent years, are still under 25 percent [<a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/62\" class=\"abstract_t\">62</a>]. Similarly, a seroepidemiology study in Hungary found that 85 percent of adults were seronegative for pertussis and therefore susceptible to infection [<a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/63\" class=\"abstract_t\">63</a>]. (See <a href=\"topic.htm?path=pertussis-infection-in-adolescents-and-adults-treatment-and-prevention#H5842133\" class=\"medical medical_review\">&quot;Pertussis infection in adolescents and adults: Treatment and prevention&quot;, section on 'Tdap booster'</a>.)</p><p class=\"headingAnchor\" id=\"H7117016\"><span class=\"h2\">Risk factors</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Adults &gt;65 years who are infected with pertussis are more likely to be hospitalized than younger adults. Obesity and preexisting asthma have been associated with a higher likelihood of developing pertussis [<a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/64\" class=\"abstract_t\">64</a>]. In one study of older teenagers and adults, household contact with a younger teenager increased the risk of pertussis, whereas professional contact with children &lt;1 year of age decreased the risk [<a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/65\" class=\"abstract_t\">65</a>].</p><p class=\"headingAnchor\" id=\"H269764\"><span class=\"h1\">PATHOGENESIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>B. pertussis</em> is transmitted via aerosolized respiratory droplets. It produces a number of biologically active substances and virulence factors that promote cellular attachment, cause local tissue damage or systemic manifestations, and interfere with host defense mechanisms (<a href=\"image.htm?imageKey=ID%2F76173\" class=\"graphic graphic_table graphicRef76173 \">table 1</a>). After inhalation, the organism adheres to ciliated respiratory epithelial cells of the upper respiratory tract and nasopharynx. A variety of protein adhesins have been implicated in the attachment process; these demonstrate a substantial degree of redundancy [<a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/3\" class=\"abstract_t\">3</a>]. Once attached, they induce local tissue damage via tracheal cytotoxin, dermonecrotic toxin, or adenylate cyclase; this destructive process, with loss of the protective respiratory cells, is likely responsible for microaspiration and therefore for the cough.</p><p>Histopathological analysis, using a novel immunohistochemical technique, of tissue samples obtained from cases of fatal pertussis infection in infants revealed intracellular organisms in alveolar macrophages as well as the ciliated respiratory epithelial cells [<a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/66\" class=\"abstract_t\">66</a>]. This may explain the prolonged duration of cough. The most notable systemic laboratory manifestation is lymphocytosis, which is caused by pertussis toxin (PT). PT may also cause hyperinsulinemia with resultant hypoglycemia in young infants [<a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/67,68\" class=\"abstract_t\">67,68</a>].</p><p>Following infection, antibodies to a variety of antigens develop, including PT, filamentous hemagglutinin, pertactin, fimbriae <span class=\"nowrap\">2/3,</span> lipopolysaccharide, and adenylate cyclase. Many of these antigens form the components of pertussis vaccines. Pertactin, a virulence factor that is thought to promote adherence of <em>B. pertussis</em> to the upper respiratory epithelium, is a pertussis acellular vaccine immunogen. A screening study of 1300 surveillance and outbreak isolates in the United States demonstrated a dramatic increase in pertactin-deficient <em>B. pertussis </em>isolates [<a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/69\" class=\"abstract_t\">69</a>]. In addition, an association has been observed between prior (acellular) vaccination and infection with pertactin-deficient <em>B. pertussis</em>, suggesting that previously vaccinated individuals are more susceptible to this strain [<a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/70\" class=\"abstract_t\">70</a>].</p><p class=\"headingAnchor\" id=\"H252275031\"><span class=\"h1\">SUMMARY</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><em>Bordetella pertussis</em> is a fastidious gram-negative coccobacillus that requires special media for culture. It is exclusively a human pathogen. (See <a href=\"#H270844\" class=\"local\">'Microbiology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The incubation period for <em>B. pertussis</em> is typically one week but may be three weeks or longer. (See <a href=\"#H252275003\" class=\"local\">'Transmission'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The introduction of the whole-cell pertussis vaccine in the United States in the late 1940s led to a dramatic decline in disease incidence; however, the number of reported cases in the United States and many other countries has been steadily rising since the 1970s. The newer acellular pertussis vaccines appear to be less efficacious than the whole-cell vaccines used previously. (See <a href=\"#H252275010\" class=\"local\">'Incidence'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Adolescents and adults with unrecognized pertussis represent a reservoir of infection for infants and children, in whom infection is associated with substantially higher morbidity and mortality. Booster vaccination of adolescents and adults is recommended. (See <a href=\"#H252275017\" class=\"local\">'Evolving epidemiology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><em>B. pertussis</em> is highly contagious and is transmitted via aerosolized respiratory droplets. After inhalation, the organism adheres to ciliated respiratory epithelial cells of the upper respiratory tract and nasopharynx, causing local tissue damage. (See <a href=\"#H269764\" class=\"local\">'Pathogenesis'</a> above.)</p><p/><p class=\"headingAnchor\" id=\"H252275812\"><span class=\"h1\">ACKNOWLEDGMENT</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The editorial staff at UpToDate would like to acknowledge Dr. Christopher Ohl, who contributed to an earlier version of this topic review.</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/1\" class=\"nounderline abstract_t\">Liang Y, Salim AM, Wu W, Kilgore PE. Chao Yuanfang: Imperial Physician of the Sui Dynasty and an Early Pertussis Observer? Open Forum Infect Dis 2016; 3:ofw017.</a></li><li class=\"breakAll\">Cotter PA, Miller JF. Bordetella. In: Principles of bacterial pathogenesis, Groisman EA (Ed), Academic Press, Ltd, London 2001. p.619.</li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/3\" class=\"nounderline abstract_t\">Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 2005; 18:326.</a></li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/4\" class=\"nounderline abstract_t\">Cherry JD, Seaton BL. Patterns of Bordetella parapertussis respiratory illnesses: 2008-2010. Clin Infect Dis 2012; 54:534.</a></li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/5\" class=\"nounderline abstract_t\">Koepke R, Bartholomew ML, Eickhoff JC, et al. Widespread Bordetella parapertussis Infections-Wisconsin, 2011-2012: Clinical and Epidemiologic Features and Antibiotic Use for Treatment and Prevention. Clin Infect Dis 2015; 61:1421.</a></li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/6\" class=\"nounderline abstract_t\">Woolfrey BF, Moody JA. Human infections associated with Bordetella bronchiseptica. Clin Microbiol Rev 1991; 4:243.</a></li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/7\" class=\"nounderline abstract_t\">Weyant RS, Hollis DG, Weaver RE, et al. Bordetella holmesii sp. nov., a new gram-negative species associated with septicemia. J Clin Microbiol 1995; 33:1.</a></li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/8\" class=\"nounderline abstract_t\">Yih WK, Silva EA, Ida J, et al. Bordetella holmesii-like organisms isolated from Massachusetts patients with pertussis-like symptoms. Emerg Infect Dis 1999; 5:441.</a></li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/9\" class=\"nounderline abstract_t\">Rodgers L, Martin SW, Cohn A, et al. Epidemiologic and laboratory features of a large outbreak of pertussis-like illnesses associated with cocirculating Bordetella holmesii and Bordetella pertussis--Ohio, 2010-2011. Clin Infect Dis 2013; 56:322.</a></li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/10\" class=\"nounderline abstract_t\">Tartof SY, Gounder P, Weiss D, et al. Bordetella holmesii bacteremia cases in the United States, April 2010-January 2011. Clin Infect Dis 2014; 58:e39.</a></li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/11\" class=\"nounderline abstract_t\">Pittet LF, Emonet S, Schrenzel J, et al. Bordetella holmesii: an under-recognised Bordetella species. Lancet Infect Dis 2014; 14:510.</a></li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/12\" class=\"nounderline abstract_t\">Warfel JM, Beren J, Merkel TJ. Airborne transmission of Bordetella pertussis. J Infect Dis 2012; 206:902.</a></li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/13\" class=\"nounderline abstract_t\">Deen JL, Mink CA, Cherry JD, et al. Household contact study of Bordetella pertussis infections. Clin Infect Dis 1995; 21:1211.</a></li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/14\" class=\"nounderline abstract_t\">Althouse BM, Scarpino SV. Asymptomatic transmission and the resurgence of Bordetella pertussis. BMC Med 2015; 13:146.</a></li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/15\" class=\"nounderline abstract_t\">Tiwari T, Murphy TV, Moran J, National Immunization Program, CDC. Recommended antimicrobial agents for the treatment and postexposure prophylaxis of pertussis: 2005 CDC Guidelines. MMWR Recomm Rep 2005; 54:1.</a></li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/16\" class=\"nounderline abstract_t\">Bergquist SO, Bernander S, Dahnsj&ouml; H, Sundel&ouml;f B. Erythromycin in the treatment of pertussis: a study of bacteriologic and clinical effects. Pediatr Infect Dis J 1987; 6:458.</a></li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/17\" class=\"nounderline abstract_t\">Bass JW, Klenk EL, Kotheimer JB, et al. Antimicrobial treatment of pertussis. J Pediatr 1969; 75:768.</a></li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/18\" class=\"nounderline abstract_t\">Centers for Disease Control and Prevention (CDC). Pertussis--United States, 1997-2000. MMWR Morb Mortal Wkly Rep 2002; 51:73.</a></li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/19\" class=\"nounderline abstract_t\">Mink CM, Cherry JD, Christenson P, et al. A search for Bordetella pertussis infection in university students. Clin Infect Dis 1992; 14:464.</a></li><li class=\"breakAll\">Centers for Disease Control and Prevention. MMMWR. Notifiable Diseases and Mortality Tables. April 20, 2012. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6115md.htm?s_cid=mm6115md_w (Accessed on April 30, 2012).</li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/21\" class=\"nounderline abstract_t\">Winter K, Harriman K, Schechter R, et al. Notes from the field: Pertussis--California, January-June 2010. MMWR Morb Mortal Wkly Rep 2010; 59:817.</a></li><li class=\"breakAll\">Centers for Disease Control and Prevention. Pertussis (Whooping cough): Pertussis cases by year (1922-2015). https://www.cdc.gov/pertussis/surv-reporting/cases-by-year.html (Accessed on August 15, 2017).</li><li class=\"breakAll\">http://www.cdc.gov/pertussis/surv-reporting.html, (Accessed on October 17, 2013).</li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/24\" class=\"nounderline abstract_t\">Winter K, Glaser C, Watt J, et al. Pertussis epidemic--California, 2014. MMWR Morb Mortal Wkly Rep 2014; 63:1129.</a></li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/25\" class=\"nounderline abstract_t\">Chlibek R, Smetana J, Sosovickova R, et al. Seroepidemiology of whooping cough in the Czech Republic: estimates of incidence of infection in adults. Public Health 2017; 150:77.</a></li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/26\" class=\"nounderline abstract_t\">Centers for Disease Control and Prevention (CDC). Pertussis epidemic--Washington, 2012. MMWR Morb Mortal Wkly Rep 2012; 61:517.</a></li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/27\" class=\"nounderline abstract_t\">Cherry JD. The epidemiology of pertussis: a comparison of the epidemiology of the disease pertussis with the epidemiology of Bordetella pertussis infection. Pediatrics 2005; 115:1422.</a></li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/28\" class=\"nounderline abstract_t\">Cherry JD. The present and future control of pertussis. Clin Infect Dis 2010; 51:663.</a></li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/29\" class=\"nounderline abstract_t\">Pertussis vaccination: use of acellular pertussis vaccines among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1997; 46:1.</a></li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/30\" class=\"nounderline abstract_t\">LAMBERT HJ. EPIDEMIOLOGY OF A SMALL PERTUSSIS OUTBREAK IN KENT COUNTY, MICHIGAN. Public Health Rep 1965; 80:365.</a></li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/31\" class=\"nounderline abstract_t\">Jenkinson D. Duration of effectiveness of pertussis vaccine: evidence from a 10 year community study. Br Med J (Clin Res Ed) 1988; 296:612.</a></li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/32\" class=\"nounderline abstract_t\">Cody CL, Baraff LJ, Cherry JD, et al. Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics 1981; 68:650.</a></li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/33\" class=\"nounderline abstract_t\">Zhang L, Prietsch SO, Axelsson I, Halperin SA. Acellular vaccines for preventing whooping cough in children. Cochrane Database Syst Rev 2014; :CD001478.</a></li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/34\" class=\"nounderline abstract_t\">Fulton TR, Phadke VK, Orenstein WA, et al. Protective Effect of Contemporary Pertussis Vaccines: A Systematic Review and Meta-analysis. Clin Infect Dis 2016; 62:1100.</a></li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/35\" class=\"nounderline abstract_t\">Clark TA, Messonnier NE, Hadler SC. Pertussis control: time for something new? Trends Microbiol 2012; 20:211.</a></li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/36\" class=\"nounderline abstract_t\">Witt MA, Katz PH, Witt DJ. Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak. Clin Infect Dis 2012; 54:1730.</a></li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/37\" class=\"nounderline abstract_t\">Klein NP, Bartlett J, Rowhani-Rahbar A, et al. Waning protection after fifth dose of acellular pertussis vaccine in children. N Engl J Med 2012; 367:1012.</a></li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/38\" class=\"nounderline abstract_t\">Misegades LK, Winter K, Harriman K, et al. Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California, 2010. JAMA 2012; 308:2126.</a></li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/39\" class=\"nounderline abstract_t\">Tartof SY, Lewis M, Kenyon C, et al. Waning immunity to pertussis following 5 doses of DTaP. Pediatrics 2013; 131:e1047.</a></li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/40\" class=\"nounderline abstract_t\">Wessels MR, Brigham KS, DeMaria A Jr. Case records of the Massachusetts General Hospital. Case 6-2015. A 16-year-old boy with coughing spells. N Engl J Med 2015; 372:765.</a></li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/41\" class=\"nounderline abstract_t\">Klein NP, Bartlett J, Fireman B, et al. Comparative effectiveness of acellular versus whole-cell pertussis vaccines in teenagers. Pediatrics 2013; 131:e1716.</a></li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/42\" class=\"nounderline abstract_t\">Witt MA, Arias L, Katz PH, et al. Reduced risk of pertussis among persons ever vaccinated with whole cell pertussis vaccine compared to recipients of acellular pertussis vaccines in a large US cohort. Clin Infect Dis 2013; 56:1248.</a></li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/43\" class=\"nounderline abstract_t\">Skoff TH, Martin SW. Impact of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccinations on Reported Pertussis Cases Among Those 11 to 18 Years of Age in an Era of Waning Pertussis Immunity: A Follow-up Analysis. JAMA Pediatr 2016; 170:453.</a></li><li class=\"breakAll\">Centers for Disease Control and Prevention. Pertussis (Whooping Cough). Pertussis in Other Countries. http://www.cdc.gov/pertussis/countries.html.</li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/45\" class=\"nounderline abstract_t\">Centers for Disease Control and Prevention (CDC). Pertussis--United States, 2001-2003. MMWR Morb Mortal Wkly Rep 2005; 54:1283.</a></li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/46\" class=\"nounderline abstract_t\">G&uuml;ri&#351; D, Strebel PM, Bardenheier B, et al. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996. Clin Infect Dis 1999; 28:1230.</a></li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/47\" class=\"nounderline abstract_t\">Dworkin MS. Adults are whooping, but are internists listening? Ann Intern Med 2005; 142:832.</a></li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/48\" class=\"nounderline abstract_t\">Hewlett EL, Edwards KM. Clinical practice. Pertussis--not just for kids. N Engl J Med 2005; 352:1215.</a></li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/49\" class=\"nounderline abstract_t\">Tanaka M, Vitek CR, Pascual FB, et al. Trends in pertussis among infants in the United States, 1980-1999. JAMA 2003; 290:2968.</a></li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/50\" class=\"nounderline abstract_t\">Vitek CR, Pascual FB, Baughman AL, Murphy TV. Increase in deaths from pertussis among young infants in the United States in the 1990s. Pediatr Infect Dis J 2003; 22:628.</a></li><li class=\"breakAll\">Centers for Disease Control and Prevention. Pertussis (Whooping Cough). Outbreaks. http://www.cdc.gov/pertussis/outbreaks.html.</li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/52\" class=\"nounderline abstract_t\">von K&ouml;nig CH, Halperin S, Riffelmann M, Guiso N. Pertussis of adults and infants. Lancet Infect Dis 2002; 2:744.</a></li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/53\" class=\"nounderline abstract_t\">Teepe J, Broekhuizen BD, Ieven M, et al. Prevalence, diagnosis, and disease course of pertussis in adults with acute cough: a prospective, observational study in primary care. Br J Gen Pract 2015; 65:e662.</a></li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/54\" class=\"nounderline abstract_t\">Nelson JD. The changing epidemiology of pertussis in young infants. The role of adults as reservoirs of infection. Am J Dis Child 1978; 132:371.</a></li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/55\" class=\"nounderline abstract_t\">Bisgard KM, Pascual FB, Ehresmann KR, et al. Infant pertussis: who was the source? Pediatr Infect Dis J 2004; 23:985.</a></li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/56\" class=\"nounderline abstract_t\">Wendelboe AM, Njamkepo E, Bourillon A, et al. Transmission of Bordetella pertussis to young infants. Pediatr Infect Dis J 2007; 26:293.</a></li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/57\" class=\"nounderline abstract_t\">Kowalzik F, Barbosa AP, Fernandes VR, et al. Prospective multinational study of pertussis infection in hospitalized infants and their household contacts. Pediatr Infect Dis J 2007; 26:238.</a></li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/58\" class=\"nounderline abstract_t\">Edwards KM. Overview of pertussis: focus on epidemiology, sources of infection, and long term protection after infant vaccination. Pediatr Infect Dis J 2005; 24:S104.</a></li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/59\" class=\"nounderline abstract_t\">Fedele G, Carollo M, Palazzo R, et al. Parents as source of pertussis transmission in hospitalized young infants. Infection 2017; 45:171.</a></li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/60\" class=\"nounderline abstract_t\">Skoff TH, Kenyon C, Cocoros N, et al. Sources of Infant Pertussis Infection in the United States. Pediatrics 2015; 136:635.</a></li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/61\" class=\"nounderline abstract_t\">Warfel JM, Zimmerman LI, Merkel TJ. Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model. Proc Natl Acad Sci U S A 2014; 111:787.</a></li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/62\" class=\"nounderline abstract_t\">Williams WW, Lu PJ, O'Halloran A, et al. Surveillance of Vaccination Coverage among Adult Populations - United States, 2015. MMWR Surveill Summ 2017; 66:1.</a></li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/63\" class=\"nounderline abstract_t\">Torzsa P, Devadiga R, Tafalla M. Seroprevalence of Bordetella pertussis antibodies in adults in Hungary: results of an epidemiological cross-sectional study. BMC Infect Dis 2017; 17:242.</a></li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/64\" class=\"nounderline abstract_t\">Liu BC, McIntyre P, Kaldor JM, et al. Pertussis in older adults: prospective study of risk factors and morbidity. Clin Infect Dis 2012; 55:1450.</a></li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/65\" class=\"nounderline abstract_t\">Wensley A, Hughes GJ, Campbell H, et al. Risk factors for pertussis in adults and teenagers in England. Epidemiol Infect 2017; 145:1025.</a></li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/66\" class=\"nounderline abstract_t\">Paddock CD, Sanden GN, Cherry JD, et al. Pathology and pathogenesis of fatal Bordetella pertussis infection in infants. Clin Infect Dis 2008; 47:328.</a></li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/67\" class=\"nounderline abstract_t\">Christie CD, Baltimore RS. Pertussis in neonates. Am J Dis Child 1989; 143:1199.</a></li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/68\" class=\"nounderline abstract_t\">Smith C, Vyas H. Early infantile pertussis; increasingly prevalent and potentially fatal. Eur J Pediatr 2000; 159:898.</a></li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/69\" class=\"nounderline abstract_t\">Pawloski LC, Queenan AM, Cassiday PK, et al. Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States. Clin Vaccine Immunol 2014; 21:119.</a></li><li><a href=\"https://www.uptodate.com/contents/pertussis-infection-epidemiology-microbiology-and-pathogenesis/abstract/70\" class=\"nounderline abstract_t\">Martin SW, Pawloski L, Williams M, et al. Pertactin-negative Bordetella pertussis strains: evidence for a possible selective advantage. Clin Infect Dis 2015; 60:223.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 8043 Version 29.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H252275031\"><span>SUMMARY</span></a></li><li><a href=\"#H252274975\" id=\"outline-link-H252274975\">INTRODUCTION</a></li><li><a href=\"#H270844\" id=\"outline-link-H270844\">MICROBIOLOGY</a></li><li><a href=\"#H252274996\" id=\"outline-link-H252274996\">EPIDEMIOLOGY</a><ul><li><a href=\"#H252275003\" id=\"outline-link-H252275003\">Transmission</a></li><li><a href=\"#H252275010\" id=\"outline-link-H252275010\">Incidence</a></li><li><a href=\"#H252275017\" id=\"outline-link-H252275017\">Evolving epidemiology</a></li><li><a href=\"#H7117016\" id=\"outline-link-H7117016\">Risk factors</a></li></ul></li><li><a href=\"#H269764\" id=\"outline-link-H269764\">PATHOGENESIS</a></li><li><a href=\"#H252275031\" id=\"outline-link-H252275031\">SUMMARY</a></li><li><a href=\"#H252275812\" id=\"outline-link-H252275812\">ACKNOWLEDGMENT</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"ID/8043|FIG\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"FIGURES\">FIGURES</a></div><ul><li><a href=\"image.htm?imageKey=ID/83297\" class=\"graphic graphic_figure\">- Reported pertussis US 1922 to 2015</a></li><li><a href=\"image.htm?imageKey=ID/73317\" class=\"graphic graphic_figure\">- Incidence pertussis US 1990 to 2011</a></li></ul></li><li><div id=\"ID/8043|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=ID/76173\" class=\"graphic graphic_table\">- B pertussis virulence factors</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=pertussis-infection-in-adolescents-and-adults-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Pertussis infection in adolescents and adults: Clinical manifestations and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pertussis-infection-in-adolescents-and-adults-treatment-and-prevention\" class=\"medical medical_review\">Pertussis infection in adolescents and adults: Treatment and prevention</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pertussis-infection-in-infants-and-children-clinical-features-and-diagnosis\" class=\"medical medical_review\">Pertussis infection in infants and children: Clinical features and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pertussis-infection-in-infants-and-children-treatment-and-prevention\" class=\"medical medical_review\">Pertussis infection in infants and children: Treatment and prevention</a></li></ul></div></div>","javascript":null}